Racial and sex representation in clinical trials: Where are we in abdominal organ transplantation?
- PMID: 33890411
- DOI: 10.1111/ajt.16619
Racial and sex representation in clinical trials: Where are we in abdominal organ transplantation?
Keywords: clinical research/practice; clinical trial; disparities; kidney transplantation/nephrology; liver transplantation/hepatology; meta-analysis; organ transplantation in general.
References
REFERENCES
-
- Regnante JM, Richie NA, Fashoyin-Aje L, et al. US cancer centers of excellence strategies for increased inclusion of racial and ethnic minorities in clinical trials. J Oncol Pract. 2019;15(4):e289-e299.
-
- Loree JM, Anand S, Dasari A, et al. Disparity of race reporting and representation in clinical trials leading to cancer drug approvals from 2008 to 2018. JAMA Oncol. 2019;5(10):e191870.
-
- Ford JG, Howerton MW, Lai GY, et al. Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer. 2008;112(2):228-242.
-
- Flores LE, Frontera WR, Andrasik MP, et al. Assessment of the inclusion of racial/ethnic minority, female, and older individuals in vaccine clinical trials. JAMA Netw Open. 2021;4(2):e2037640.
-
- Gordon EJ, Ladner DP, Caicedo JC, Franklin J. Disparities in kidney transplant outcomes: a review. Semin Nephrol. 2010;30(1):81-89.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
